The final list of those interested in the Chelsea acquisition, updated today (27), by the Wren Group, which handles terms of sale on behalf of the team, features names with extensive experience in leading successful sports franchises located in the United States. Information from the portal telegraph. However, the sale of the blues is expected to continue until April 11, after the US company extended the deadline for potential applicants to submit their final bids.
Possible buyers include US financiers Josh Harris and Dave Pletzer, who back Britain’s Martin Broughton and Sebastian Coe’s bid. The American duo own stakes in the NBA’s Philadelphia 76ers and the New Jersey Devils, as well as being shareholders in Crystal Palace.
NBA Sacramento Kings owner Vivek Ranadive is also interested, as is MLB LA Dodgers owner Todd Boyle.
The list of finalists also includes the Ricketts family (who have already been shunned by the team’s fans due to allegations of racism) and Stephen Pagliuca (co-owner of the Boston Celtics and Atalanta, which can be seen as conflicting interests in European football).
Once final bids are received on April 11, the entire transaction can be signed, sealed and delivered by the end of the same month. The winner will also need the approval of the UK government, which has imposed a series of financial restrictions on Chelsea.
The potential buyer will also have to secure £1 billion in future investment, which is believed to be a fund to ensure players continue to invest at a pace similar to the Abramovich era.
Amelia Kensington is a contributor to Mediarunsearch.co.uk, covering a wide range of topics including news, politics, business, technology, sport, entertainment, and lifestyle. She focuses on delivering clear, balanced reporting and useful information that helps readers stay informed about current events and emerging developments. Her work highlights stories that matter to everyday audiences, presenting complex topics in an accessible and engaging way while maintaining a strong commitment to accuracy and relevance.